Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2024

Accounting Policies [Abstract]

Summary of Goodwill

The following table presents information related to goodwill for the year ended December 31, 2024.

Balance, beginning of year	$	19,188,278
AxoBio Disposition		(19,188,278	)
Balance, end of year	$	—

Summary of Securities that were Excluded from the Diluted Per Share

Potentially dilutive securities, which are not included in diluted weighted average shares outstanding for the periods ended December 31, 2024 and 2023, consist of the following (in common stock equivalents):

	December 31,
	2024		2023
Common Stock options		4,414,081		1,689,765
Common Stock warrants		4,640,929		4,638,454
Series A Preferred Stock (if converted)		—		4,243,000
Total Common Stock equivalents		9,055,010		10,571,219

Schedule of Other Financial Assets and Liabilities Recorded in Balance Sheet at Fair Value

Other financial assets and liabilities as of December 31, 2024 and 2023 are categorized based on a hierarchy of inputs as follows:

	December 31, 2024				December 31, 2023				Fair Value
	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value		Input Hierarchy
Money market accounts	$	25,374	$	25,374	$	30,000	$	30,000	Level 1
Forward purchase agreement		—		—		5,700,451		5,700,451	Level 3
SBA Loan		—		—		1,505,070		1,498,000	Level 2

Schedule of Changes in Fair Value of Level 3 Financial Assets and Liabilities

Changes in the fair value of Level 3 financial assets and liabilities for the year ended December 31, 2024 are as follows:

Forward Purchase Agreement:
Balance, beginning of year	$	5,700,451
Change in fair value		(5,445,787	)
Loss on modification of agreement		(254,664	)
Balance, end of period	$	—